Napthalimidobenzamide DB-51630: a novel DNA binding agent inducing p300 gene expression and exerting a potent anti-cancer activity

DB-51630 specifically induced p300 gene expression in cancer cells and showed a potent anti-cancer activity both in vitro and in vivo.